Jay Warrick is a Rheumatology/Immunology physician.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4707 Papermill Dr
Suite 200
Knoxville, TN 379091900
Telephone
865-602-7983Provider last certified this registry record 18 Mar 2020.
Industry payments
24 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202540 payments
- Amgen Inc.Program year202522 payments
- Janssen Biotech, Inc.Program year202512 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
85.9%TNF inhibitor45.7%Golimumab88%Infliximab12%Enbrel Sureclick0%Humira(Cf)0%Humira(Cf) Pen0%Enbrel0%Simponi0%Part D + Part B<11 patientsSelective T Cell Costimulation Modulator37.9%Abatacept100%Orencia Clickject0%Part D + Part B<11 patients+ 7 more classes in this area
Musculoskeletal
8.4%RANK Ligand Inhibitor7.7%Denosumab100%Part B, office-administered≥30 patientsCentral alpha-2 Adrenergic Agonist0.3%Tizanidine Hcl100%Part D≥31 patients+ 4 more classes in this area
Nervous system
2.2%Gabapentinoids1%Gabapentin73%Pregabalin28%Part D≥54 patientsSNRI0.3%Duloxetine Hcl59%Savella41%Part D<11 patients+ 8 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”